| 產品名稱 |
Recombinant adenovirus 5 |
| 商品貨號 |
B178526 |
| Classification |
Adenoviridae, Mastadenovirus, Simian adenovirus C |
| Agent |
Recombinant adenovirus 5 |
| Strain |
Adrab.gp |
| Applications |
Respiratory research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
recombination of adenovirus with the rabies virus protein |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
-70C or lower |
| Effect on Host |
Yes, in vitro effects: Cytopathic effects with cells becoming enlarged within clusters and finally detaching from the flask CPE with cells becoming enlarged within clusters and finally detaching from the flask. |
| Recommended Host |
293 cells (ATCC CRL-1573) Host of Choice: 293 (ATCC CRL-1573) cells Host Range: 293 cells 293 cells (ATCC CRL-1573) |
| Growth Conditions |
Duration: 2-3 days at 37C |
| Cryopreservation |
Storage temperature: -70C or lower |
| Name of Depositor |
Wistar Institute |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Special Collection |
NCRR Contract |
| Source |
recombination of adenovirus with the rabies virus protein |
| References |
Ertl HC, Wilson JM. Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier. US Patent 5,698,202 dated Dec 16 1997
|
